Azmi Nabulsi, Chief Operating Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 21,802 shares at $11.72 ($256K) on 2024-07-15, disclosed to the SEC on 2024-07-17.
Open-market sale of $256k PHAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.72 | 10,901 | $128K | 50.0% |
| 2 | $11.72 | 10,901 | $128K | 50.0% |
| Total | $11.72 avg | 21,802 | $256K | 100% |
| Filing → |
| PHAT | BUY | 2023-04-11 | $83K | — | Filing → |
| PHAT | BUY | 2022-05-16 | $163K | — | Filing → |
| PHAT | SELL | 2021-05-04 | $1.1M | — | Filing → |